Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Retained Earnings (2016 - 2025)

Aethlon Medical filings provide 15 years of Retained Earnings readings, the most recent being -$168.0 million for Q1 2025.

  • On a quarterly basis, Retained Earnings fell 2419998.23% to -$168.0 million in Q1 2025 year-over-year; TTM through Mar 2025 was -$168.0 million, a 2419998.23% decrease, with the full-year FY2025 number at -$168.0 million, down 2419998.23% from a year prior.
  • Retained Earnings hit -$168.0 million in Q1 2025 for Aethlon Medical, down from -$17026.0 in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of -$1619.0 in Q4 2023 to a low of -$168.0 million in Q1 2025.
  • Median Retained Earnings over the past 5 years was -$124.0 million (2021), compared with a mean of -$88.3 million.
  • Biggest five-year swings in Retained Earnings: surged 100.0% in 2023 and later plummeted 2419998.23% in 2025.
  • Aethlon Medical's Retained Earnings stood at -$126.5 million in 2021, then decreased by 10.55% to -$139.9 million in 2022, then surged by 100.0% to -$1619.0 in 2023, then plummeted by 951.64% to -$17026.0 in 2024, then plummeted by 986360.81% to -$168.0 million in 2025.
  • The last three reported values for Retained Earnings were -$168.0 million (Q1 2025), -$17026.0 (Q4 2024), and -$3969.0 (Q3 2024) per Business Quant data.